MENU
+Compare
SYNB
ETF ticker: NYSE ARCA
AS OF
Nov 13 closing price
Price
$31.61
Change
+$0.59 (+1.90%)
Net Assets
1.58M

SYNB stock forecast, quote, news & analysis

The investment seeks long term capital appreciation... Show more

Category: #Health
SYNB
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SYNB with price predictions
Nov 18, 2025

SYNB in +3.59% Uptrend, rising for three consecutive days on October 24, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SYNB advanced for three days, in of 162 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SYNB just turned positive on November 17, 2025. Looking at past instances where SYNB's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 145 cases where SYNB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SYNB moved out of overbought territory on November 05, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on November 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SYNB as a result. In of 50 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYNB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SYNB broke above its upper Bollinger Band on October 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Alphabet (NASDAQ:GOOGL), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Regeneron Pharmaceuticals (NASDAQ:REGN), ZOETIS (NYSE:ZTS), Biogen (NASDAQ:BIIB), DuPont de Nemours (NYSE:DD), Exact Sciences Corp (NASDAQ:EXAS).

Industry description

The investment seeks long term capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on “biology revolution” companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.

Market Cap

The average market capitalization across the Putnam BioRevolution ETF ETF is 264.48B. The market cap for tickers in the group ranges from 317.63M to 4.42T. NVDA holds the highest valuation in this group at 4.42T. The lowest valued company is RCKT at 317.63M.

High and low price notable news

The average weekly price growth across all stocks in the Putnam BioRevolution ETF ETF was 27%. For the same ETF, the average monthly price growth was 38%, and the average quarterly price growth was 94%. ONON experienced the highest price growth at 21%, while TWST experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Putnam BioRevolution ETF ETF was 26%. For the same stocks of the ETF, the average monthly volume growth was 20% and the average quarterly volume growth was 173%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 63
Price Growth Rating: 48
SMR Rating: 66
Profit Risk Rating: 67
Seasonality Score: 15 (-100 ... +100)
View a ticker or compare two or three
SYNB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Putnam ETF Trus100 FEDERAL STREET
Phone
6177601060
Web
N/A